Form 4 for ICUI ICU MEDICAL INC/DE
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-06 · accession 0001410442-22-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-08 | 2022-03-06+ | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | +5,740 | 14.6K | +65% | $0 |
| DM | 2022-03-08 | 2022-03-06+ | ICUI | Jain Vivek | COB, CEO, Dir | F - Tax | $136.11 | -3,020 | 15.5K | -16% | -$411.0K |
| DM | 2022-03-08 | 2022-03-06+ | ICUI | Jain Vivek | COB, CEO, Dir | M - OptEx | $0.00 | -5,740 | 1,773 | -76% | $0 |
| D | 2022-03-08 | 2022-03-07 | ICUI | Jain Vivek | COB, CEO, Dir | A - Grant | $0.00 | +9,654 | 9,654 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-08 | M | A | 2,524 | $0.00 | 16,827 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-06 | F | D | 932 | $242.93 | 13,619 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-06 | M | A | 1,444 | $0.00 | 15,063 | D | — | — | (F1) These securities are Restricted Stock Units. |
| 4 | Common | Common Stock | 2022-03-06 | F | D | 760 | $242.93 | 14,303 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-08 | F | D | 1,328 | $0.00 | 15,499 | D | — | — | |
| 6 | Common | Common Stock | 2022-03-06 | M | A | 1,772 | $0.00 | 14,551 | D | — | — | |
| 7 | Derivative | Common Stock | 2022-03-06 | M | D | 1,444 | $0.00 | 0 | D | — · — to 2022-03-06 | 1,444 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |
| 8 | Derivative | Common Stock | 2022-03-07 | A | A | 9,654 | $0.00 | 9,654 | D | $0.00 · — to 2025-03-07 | 9,654 Common Stock | (F1) These securities are Restricted Stock Units. (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |
| 9 | Derivative | Common Stock | 2022-03-08 | M | D | 2,524 | $0.00 | 5,050 | D | $0.00 · 2022-03-08 to 2024-03-08 | 2,524 Common Stock | (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. |
| 10 | Derivative | Common Stock | 2022-03-06 | M | D | 1,772 | $0.00 | 1,773 | D | $0.00 · 2022-03-06 to 2023-03-06 | 1,772 Common Stock | (F3) There is neither a purchase price nor an exercise price for the Restricted Stock Units. (F4) One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. (F5) These are restricted stock units that fully vest 3 years from the grant date. |